Loading…
Underlying
Underlying Price
$169.26
Type
Put
Strike
158
Expiration
Nov 20, 2026
DTE
44d
Moneyness
OTM
Intrinsic
$0.00
XLV 158 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 9, 2026 | 2d | $0.27 | +0.00% | 8 | 8 |
| Oct 16, 2026 | 9d | $0.13 | +8.33% | 2 | 162 |
| Oct 23, 2026 | 16d | $0.20 | -23.08% | 2 | 121 |
| Oct 30, 2026 | 23d | $0.52 | -22.39% | 6 | 35 |
| Nov 6, 2026 | 30d | $0.54 | -31.65% | 1 | 8 |
| Nov 13, 2026 | 37d | — | — | 0 | 0 |
| Nov 20, 2026 | 44d | $0.97 | -3.00% | 9 | 122 |
| Dec 18, 2026 | 72d | $1.64 | -1.20% | 6 | 2,258 |
| Jan 15, 2027 | 100d | $2.30 | -14.81% | 62 | 152 |
| Mar 19, 2027 | 163d | $3.00 | +4.90% | 2 | 144 |
| Jun 17, 2027 | 253d | — | — | 0 | 0 |
| Jan 19, 2029 | 835d | — | — | 0 | 0 |
XLV Nearby Strikes · Nov 20, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 150 P | $0.21 | -4.55% | 4 | 626 | OTM |
| 153 P | $0.43 | -4.44% | 46 | 55 | OTM |
| 154 P | $0.58 | +26.09% | 4 | 7 | OTM |
| 155 P | $0.62 | +5.08% | 24 | 5,119 | OTM |
| 156 P | $0.65 | -26.14% | 1 | 48 | OTM |
| 157 P | $0.81 | -3.57% | 15 | 81 | OTM |
| 158 P | $0.97 | -3.00% | 9 | 122 | OTM |
| 159 P | $1.58 | +9.72% | 33 | 163 | OTM |
| 160 P | $1.31 | -2.24% | 54 | 2,460 | OTM |
| 161 P | $1.54 | -27.36% | 119 | 179 | OTM |
| 162 P | $1.82 | -1.09% | 12 | 501 | OTM |
| 163 P | $2.13 | +2.40% | 19 | 76 | OTM |
| 164 P | $2.51 | -19.03% | 14 | 116 | OTM |
XLV Profile
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.